AbbVie’s Imbruvica and Rituxan Combo Snags FDA Approval for Rare Blood DiseaseAllbiopro2018-08-28T01:18:00+09:008월 28th, 2018|
Esperion’s Bemopedoic Acid Treatments Hit the Mark in Two StudiesAllbiopro2018-08-28T01:17:32+09:008월 28th, 2018|
FDA Action Alert: Ortho Dermatologics, Tetraphase Pharma, Akcea and MoreAllbiopro2018-08-28T01:17:05+09:008월 28th, 2018|
23andMe to Disable API Access to Outside App Developers: ReportAllbiopro2018-08-28T01:16:38+09:008월 28th, 2018|
ESC: Johnson & Johnson hunts for silver lining as Xarelto bombs blood clot, heart failure studiesAllbiopro2018-08-28T01:16:11+09:008월 28th, 2018|
AbbVie, Johnson & Johnson grab another Imbruvica nod with early OK in rare blood cancerAllbiopro2018-08-28T01:15:42+09:008월 28th, 2018|
With Kymriah nod in EU, Novartis is building a plant with up to 450 jobsAllbiopro2018-08-28T01:15:14+09:008월 28th, 2018|
Satan, holy water and pharma ads: Senators get fiery in push to pass DTC price tag ruleAllbiopro2018-08-28T01:14:47+09:008월 28th, 2018|
Hey, pharma marketers: Print is still relevant, and CMI/Compas has the receiptsAllbiopro2018-08-28T01:14:19+09:008월 28th, 2018|
Pfizer eyes ATTR cardiomyopathy filing for tafamidis after acing phase 3 trialAllbiopro2018-08-28T01:13:52+09:008월 28th, 2018|
Allen-backed team uncovers distinctive human brain cell that may help control information flowAllbiopro2018-08-28T01:13:24+09:008월 28th, 2018|
Substance abuse, neurological disease and more can speed up brain agingAllbiopro2018-08-28T01:12:03+09:008월 28th, 2018|
Y-mAbs preps $92M IPO to push lead assets through regulatory filingAllbiopro2018-08-28T01:11:36+09:008월 28th, 2018|
Protection For Nerve Cells Delivered Through The NoseAllbiopro2018-08-28T01:10:44+09:008월 28th, 2018|
c-LEcta lays foundation for further growth and closes financing roundAllbiopro2018-08-28T01:10:17+09:008월 28th, 2018|
